C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival

Increased fibroblast growth factor 23 (FGF23) is a risk factor for mortality, cardiovascular disease, and progression of chronic kidney disease. Limited data exist comparing the association of either c-terminal FGF23 (cFGF23) or intact FGF23 (iFGF23) in kidney transplant recipients (KTRs) with overa...

Full description

Saved in:
Bibliographic Details
Main Authors: Chu, Chang (Author) , Elitok, Saban (Author) , Zeng, Shufei (Author) , Xiong, Yingquan (Author) , Hocher, Carl-Friedrich (Author) , Hasan, Ahmed A. (Author) , Krämer, Bernhard (Author) , Hocher, Berthold (Author)
Format: Article (Journal)
Language:English
Published: 08 April 2021
In: BMC nephrology
Year: 2021, Volume: 22, Pages: 1-8
ISSN:1471-2369
DOI:10.1186/s12882-021-02329-7
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12882-021-02329-7
Get full text
Author Notes:Chang Chu, Saban Elitok, Shufei Zeng, Yingquan Xiong, Carl-Friedrich Hocher, Ahmed A. Hasan, Bernhard K. Krämer and Berthold Hocher
Description
Summary:Increased fibroblast growth factor 23 (FGF23) is a risk factor for mortality, cardiovascular disease, and progression of chronic kidney disease. Limited data exist comparing the association of either c-terminal FGF23 (cFGF23) or intact FGF23 (iFGF23) in kidney transplant recipients (KTRs) with overall (all-cause) graft loss.
Item Description:Gesehen am 12.07.2021
Physical Description:Online Resource
ISSN:1471-2369
DOI:10.1186/s12882-021-02329-7